Envy Medical Adds CMO

Envy Medical Products, Inc. welcomed Shauna Lahiri in the newly created role of chief marketing officer.  Lahiri brings a 17-year record of building successful global marketing strategies, building and launching new brands achieving leadership in mass, consumer and niche categories. She will be responsible for marketing, e-commerce and digital media development.
 
Lahiri began her career at Valeant Pharmaceuticals, developing the Kinerase marketing platform while also leading management and marketing of pharmaceutical brands in psoriasis care and hormone replacement therapies. She then went on to become the executive director of international marketing for Guthy-Renker LLC, driving the international division to become a  $450 million entity in under six years. She led the international marketing team for all flagship brands such as Proactiv, WEN Hair Care, Meaningful Beauty and Sheer Cover.
 
Lahiri was then named a partner of In Response LLC, a direct-response beauty care company where she managed all brand development and launch strategies for their flagship hair care brand and developed all customer acquisition and retention campaign strategies. Since 2012, she has been the founder and Chief Global Brand Strategist of Ignition Beauty, providing executive level strategic guidance, marketing, brand and launch strategy for Health, Beauty, CPG, Pharmaceutical, Aesthetic, Direct-to-Consumer, E-commerce and Direct-Selling organizations. Her clients have included start-ups to some of the best-known beauty and personal care brands in the world.  Lahiri received her MBA from Wayne State University and has a BS in Commerce, Marketing and Business Policy from the University of Windsor.
 
Lahiri’s appointment follows the successful professional brand skincare launches of the Lumixyl Topical Brightening System of products, an innovative hydroquinone-free skin brightening range based on the proprietary Lumixyl Decapeptide-12 technology; ClarityMD Acne Solution, a natural botanical based 2-step acne system that clears acne exceptionally fast without causing the redness and irritation commonly found in other commercially available acne products.  In 2014, Envy raised new investment capital with HCP Capital Partners to further support the commercialization of the Envy technology portfolio.
 
“Shauna is joining Envy at an exciting stage in our growth and company development,” said Curtis A. Cluff, Envy’s CEO.  “She has a uniquely powerful combination of strategic thinking and deep industry experience, particularly for bringing new products and technologies to market. We have what we believe is the most exciting portfolio in professional skincare today and Shauna brings exactly the skillset and high-level passion required for driving the success these technologies inherently deserve.”  
 
“Envy Medical products have a strong value proposition for patients and consumers worldwide who are seeking highly effective skincare with multi-faceted functionality without downtime or safety concerns,” commented Lahiri.  “The entire skincare industry trend has been moving toward the positioning that Envy’s SilkPeel, Lumixyl and ClarityMD branded products already occupy; I am looking forward to expanding the company’s presence and stature in personal care markets world-wide.”